Heath E - Search Results

1

Cediranib inhibits both the intraosseous growth of PDGF D-positive prostate cancer cells and the associated bone reaction.

Najy AJ, Jung YS, Won JJ, Conley-LaComb MK, Saliganan A, Kim CJ, Heath E, Cher ML, Bonfil RD, Kim HR. Najy AJ, et al. Among authors: heath e. Prostate. 2012 Sep 1;72(12):1328-38. doi: 10.1002/pros.22481. Epub 2011 Dec 27. Prostate. 2012. PMID: 22213159 Free PMC article.

2

A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.

Heath EI, Gaskins M, Pitot HC, Pili R, Tan W, Marschke R, Liu G, Hillman D, Sarkar F, Sheng S, Erlichman C, Ivy P. Heath EI, et al. Clin Prostate Cancer. 2005 Sep;4(2):138-41. doi: 10.3816/cgc.2005.n.024. Clin Prostate Cancer. 2005. PMID: 16197617 No abstract available.

3

New targets in the management of prostate cancer.

Heath EI, Carducci MA. Heath EI, et al. Hematol Oncol Clin North Am. 2006 Aug;20(4):985-99, xi. doi: 10.1016/j.hoc.2006.05.001. Hematol Oncol Clin North Am. 2006. PMID: 16861127 Review.

4

Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.

Ahmad IU, Forman JD, Sarkar FH, Hillman GG, Heath E, Vaishampayan U, Cher ML, Andic F, Rossi PJ, Kucuk O. Ahmad IU, et al. Among authors: heath e. Nutr Cancer. 2010;62(7):996-1000. doi: 10.1080/01635581.2010.509839. Nutr Cancer. 2010. PMID: 20924975 Free PMC article. Clinical Trial.

5

Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.

Kong D, Heath E, Chen W, Cher M, Powell I, Heilbrun L, Li Y, Ali S, Sethi S, Hassan O, Hwang C, Gupta N, Chitale D, Sakr WA, Menon M, Sarkar FH. Kong D, et al. Among authors: heath e. Am J Transl Res. 2012;4(1):14-23. Epub 2012 Jan 5. Am J Transl Res. 2012. PMID: 22347519 Free PMC article.

6

Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM.

Kong D, Heath E, Chen W, Cher ML, Powell I, Heilbrun L, Li Y, Ali S, Sethi S, Hassan O, Hwang C, Gupta N, Chitale D, Sakr WA, Menon M, Sarkar FH. Kong D, et al. Among authors: heath e. PLoS One. 2012;7(3):e33729. doi: 10.1371/journal.pone.0033729. Epub 2012 Mar 19. PLoS One. 2012. PMID: 22442719 Free PMC article. Clinical Trial.

7

Current challenges in development of differentially expressed and prognostic prostate cancer biomarkers.

Lucas SM, Heath EI. Lucas SM, et al. Prostate Cancer. 2012;2012:640968. doi: 10.1155/2012/640968. Epub 2012 Aug 28. Prostate Cancer. 2012. PMID: 22970379 Free PMC article.

8

Erratum: Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.

Kong D, Heath E, Chen W, Cher M, Powell I, Heilbrun L, Li Y, Ali S, Sethi S, Hassan O, Hwang C, Gupta N, Chitale D, Sakr W, Menon M, Sarkar F. Kong D, et al. Among authors: heath e. Am J Transl Res. 2013 Dec 1;6(1):102-103. eCollection 2013. Am J Transl Res. 2013. PMID: 24349627 Free PMC article.

9

Promising areas of prostate cancer research.

Heath EI. Heath EI. Cancer Metastasis Rev. 2014 Sep;33(2-3):375-6. doi: 10.1007/s10555-013-9491-z. Cancer Metastasis Rev. 2014. PMID: 24469850 No abstract available.

10

Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.

Mainetti LE, Zhe X, Diedrich J, Saliganan AD, Cho WJ, Cher ML, Heath E, Fridman R, Kim HR, Bonfil RD. Mainetti LE, et al. Among authors: heath e. Int J Cancer. 2015 Jan 1;136(1):11-20. doi: 10.1002/ijc.28948. Epub 2014 May 20. Int J Cancer. 2015. PMID: 24798488 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

614 results

Search Page

Filters